ARTICLE | Clinical News
CryptoGAM anti-cryptosporidiosis passive antibody: Will start Phase I trial
March 28, 1994 8:00 AM UTC
ImmuCell Corp. (ICCC), Portland, Maine Product: New formulation of CryptoGAM anti-cryptosporidiosis passive antibody Indication: Enteric cryptosporidiosis in immune-compromised patients Status: Will ...